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Contemporary Stent Treatment of 
Coronary Bifurcations
Ioannis Iakovou, MD
A B S T R A C T
Treatment of coronary bifurcations is a tantalizing problem of interventional cardiol-
ogy. The introduction of drug-eluting stents (DES) reduced restenosis in the main 
branch. However, restenosis at the ostium of the side branch remains a problem. 
While stenting the main branch with provisional side branch stenting seems to be 
the prevailing approach, in the era of DES various two-stent techniques emerged 
(“crush”) or were re-introduced (“V” or “simultaneous kissing stents”, “crush”, “T”, 
“culottes”, “Y”, “Skirt”) to allow stenting in the side branch when needed.
Recent advances in percutaneous coronary interventions (PCI) and lately the in-
troduction of drug-eluting stents (DES) have led to a dramatic increase in the number 
of patients treated percutaneously [1-5]. Bifurcation lesions are one of these complex 
lesion subsets that are now being confronted more frequently [6,7].
Several studies have shown that bifurcation when compared to non-bifurcation 
interventions have lower rate of procedural success and higher rate of restenosis [8-
10]. Various techniques with use of 1 or 2 stents have been developed to optimize the 
treatment of this subset of lesions [8-17]. Paradoxically, while stenting of individual 
lesions has been shown to be superior to balloon angioplasty, stenting of both branches 
seems to offer no advantage over stenting of the main branch (MB) alone [10].
The recent introduction of DES has resulted in a lower event rate and reduction of 
main branch restenosis in comparison with historical controls [18]. Up to now, there are 
only 2 randomized studies and some observational reports that specifically addressed 
the issue of bifurcational lesion treatment with DES [18-20]. The recently published 
Sirolimus-eluting stent bifurcational study has given us some important initial direction 
to structure our approach toward the optimal treatment of bifurcational lesions [18]. 
This study was a 5-center randomized trial to assess feasibility and safety of treatment 
of patients with sirolimus-eluting stents (Cypher, Cordis/Johnson & Johnson, Warren, 
NJ) at true bifurcational lesions (>50% stenosis in both main vessel and ostium of 
side branch) that enrolled 85 patients (86 lesions). Two different strategies were used: 
Group A-elective use of two Cypher stents and Group B-the implantation of a single 
Cypher stent in the main branch with balloon dilatation across the stent struts for the 
side branch. The protocol allowed the investigators to switch to double stenting if flow 
impairment or residual ostial stenosis >50% developed in the side branch. Twenty-two 
out of 43 patients randomized to group B crossed over, resulting in implantation of 
two stents. The total restenosis rate at 6 months was 25.7%, and it was not significantly 
different between the double-stenting (28.0%) and the provisional side branch-stenting 
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(18.7%) groups. The majority of the restenosis cases occurred 
at the ostium of the side branch and was focal. In the second 
randomized study (single center, n=91), Pan et al. compared 
stenting the main branch and balloon dilatation for the side 
branch to stenting for both branches. Similarly to the previ-
ous study there were no statistically significant differences 
between the 2 strategies [20].
T H R O M B O T I C  I S S U E S  A F T E R  D E S  
I M P L A N T A T I O N  I N  B I F U R C A T I O N S
Pathological studies have suggested that arterial branch 
points are foci of low shear and low flow velocity and are 
sites predisposed to the development of atherosclerotic plaque, 
thrombus, and inflammation [21-23]. The two or even three 
layers of struts (with “Crush”) of DES apposed to the ves-
sel wall initially raised concerns about possible increased 
thrombogenicity. Furthermore, delayed endothelialisation 
associated with DES may extend the risk of thrombosis be-
yond 30 days [24]. In the Sirolimus-eluting stent bifurcational 
study the rate of stent thrombosis was 3.5%. Very recently, 
we reported a rate of 3.6% of cumulative stent thrombosis 
after DES implantation in bifurcations in a prospective ob-
servational cohort study which included 2229 patients treated 
with both sirolimus (n=1062 patients) and paclitaxel-eluting 
stents (n=1167 patients, Taxus, Boston Scientific, Natick, MA) 
[25]. In this study, bifurcation lesion treatment was identified 
as independent predictor of subacute (post-procedure to 30 
days), late (>30 days), and cumulative thrombosis. However, 
there were no significant differences regarding the incidence 
of thrombosis in bifurcations treated with one versus two 
stents [25].
P R O V I S I O N A L  O R  T W O  S T E N T S
In general, if we take the decision to use 1 stent (at the 
main branch) there is almost always the possibility to place 
a second stent on the side branch in case the result is not op-
timal or adequate. This condition is defined as “provisional 
stenting”.
In order to decide whether to place 1 stent or 2, we have to 
consider [1] if the side branch is of adequate size, length, and 
anatomical distribution suitable to be treated with a stent and 
[2] if the side branch has a stenosis at the ostium over 50%. 
If the answer is NO to both questions we will use provisional 
stenting at the main branch, if YES we will place a second 
stent at the side branch.
A number of techniques are available with various levels 
of complexity and indications: the “V”, the “Simultaneous 
Kissing Stents” (“SKS”), “Crush” and its variations (“reverse” 
and “step”), “T” and its variation (“modified”), “Culottes”, 
“Y” and “Skirt”. The most commonly used techniques for 2 
stent placement are the first 3 and will be described in detail 
below.
T H E  “ V ”  A N D  T H E  “ S I M U L T A N E O U S  
K I S S I N G  S T E N T S ”  T E C H N I Q U E
The “V” technique includes the delivery and implantation 
of 2 stents together. One stent is advanced in the side branch, 
the other in the main branch, and the 2 stents touch each 
other forming a proximal carina (Figure 1) [26,27]. When 
this carina extends to a considerable length (usually 5 mm or 
more) into the main vessel then this technique is denominated 
as “SKS” [28]. The type of lesions we consider most suitable 
for this technique are very proximal lesions such as bifurcation 
lesions located at the left main stem with a left main artery 
which is short or free of disease. Ideally the angle between 
the two branches should be less than 90°. The “V” technique 
is also suitable for other bifurcations provided the portion of 
the vessel proximal to the bifurcation is free of disease and 
there is no need to deploy a stent more proximally.
Pros: The main advantage of these techniques is that the 
access to any of the 2 branches is never lost. In addition, when 
a final kissing (FK) inflation is performed there is no need 
to recross any stent.
Cons: When using these techniques a metallic neocarina is 
FIGURE 1. The “V” and “Simultaneous Kissing Stents” Stent-
ing Technique. (Abbreviations: FK= Final Kissing, MB= Main 
Branch, SKS= Simultaneous Kissing Stents).
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created within the vessel proximal to the bifurcation. Theoreti-
cal concerns about the risk of thrombosis related to this new 
carina have not been confirmed in our and other operators’ 
experience [19,29]. It is quite intuitive how problematic may 
be the need to position a stent proximally to the double barrel. 
There is an inevitable bias towards one of the two branches 
and the high likelihood to leave a gap.
T H E  “ C R U S H ”  T E C H N I Q U E  
A N D  I T S  V A R I A T I O N S
The “Crush” technique [15] was introduced at the time of 
DES introduction and is described schematically in Figure 2. 
Two stents are placed in the main branch and the side branch 
with the former more proximally than the latter. The stent of 
the side branch will be deployed and its balloon and wire will 
be removed. The stent subsequently deployed in the main 
branch will flatten the protruding cells of the side branch 
stent hence the denomination “Crushing” or “Crush”. Wire 
re-crossing and dilatation of the side branch with a balloon of 
at least equal diameter with the stent [30], and then FK balloon 
inflation is recommended. The implementation of FK balloon 
inflation is done in order to allow better strut contact against 
the ostium of the side branch and therefore better drug deliv-
ery [19,30]. The “Crush” technique became therefore a sort 
of simplified “Culottes” technique. After the implementation 
of the FK inflation as part of the refinement of the technique, 
restenosis at the ostium of the side branch seems to decrease. 
The positive aspect is that whenever restenosis occurs, this 
narrowing is very focal (less than 5 mm in length) and most 
of the times not associated with symptoms or ischemia.  An 
important element to keep in mind when planning to perform 
the “Crush” technique is that the two available DES will reach 
different maximal opening of their cells [19,29]. The maximal 
cell diameter will be 3.0 mm for the Cypher stent and 3.7 mm 
for the Taxus stent. This data should be kept in mind when 
the side branch has a diameter over 3.0 mm.
Pros: The main advantage of the “Crush” technique is that 
the immediate patency of both branches is assured. This gain 
is important when the side branch is functionally relevant or 
difficult to be wired. In addition provides excellent coverage of 
the ostium of the side branch, which is the main disadvantage 
of the simpler “T” technique (see below).
Cons: The main disadvantage is that the performance of 
the FK balloon inflation makes the procedure more labori-
ous due to the need to re-cross multiple struts with a wire 
and a balloon.
The main variations of the “classic Crush” technique are 
the “reverse” and the “step Crush” which can both be per-
formed utilizing a 6 F guiding catheter.
“ T ”  T E C H N I Q U E
The classic “T” technique consists in positioning a stent 
first at the ostium of the side branch being careful to avoid 
the stent protrusion in the main branch (Figure 3). Some op-
erators leave a balloon in the main branch to help to further 
locate the main branch. Following deployment of the stent and 
removal of the balloon and the wire from the side branch, a 
second stent is advanced in the main branch. A wire is then 
re-advanced into the side branch and FK balloon inflation 
is performed.
Pros: It is less laborious than “Crush”. Unlike the “V” 
it can be used for the coverage of proximal to bifurcation 
lesions.
Cons: In almost all of the cases, this technique will lead 
to incomplete coverage of the ostium of the side branch. At 
the present time in our practice, the above technique has been 
abandoned, and now there are 2 reasons to perform the “T” 
technique: 1) to place a stent at the ostium of a side branch 
following placement of a stent in the main branch because the 
result at the side branch ostium was evaluated as unsatisfac-
tory (provisional side branch stenting), 2) to perform stenting 
at the ostium of the side branch when there is isolated side 
branch ostial stenosis.
FIGURE 2. “Crush” technique (Abbreviations: FK= Final Kiss-
ing, MB= Main Branch, SB= Side branch).
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C O N C L U S I O N S
With the use of DES the restenosis at the ostium of the 
side branch is single digit and the restenosis in the side branch, 
when it occurs it is most of the times focal. When the side 
branch is not severely diseased, implantation of a stent in the 
main branch and provisional stenting in the side branch is the 
preferred strategy. Implantation of 2 stents as initial approach 
is appropriate when both branches are significantly diseased 
(diameter stenosis >50%) and suitable for stenting. A number 
of techniques are available with various levels of complexity 
and indications: the “V”, simultaneous kissing stent (SKS), 
“Crush”, “T”, “Culottes”, “Y”, and “Skirt”.
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